Literature DB >> 15447668

MAPK recruitment by beta-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time.

Karen A Bell1, Kenneth J O'Riordan, J David Sweatt, Kelly T Dineley.   

Abstract

Elevated beta-amyloid is thought to trigger the onset of Alzheimer's disease. Alzheimer's disease is marked by progressive loss of cognitive function, an early symptom of which is episodic memory deficits. Impairment of episodic memory is linked to hippocampal pathology. We investigated the signal transduction consequences of exposure to nanomolar to low micromolar concentrations of aggregate forms of beta-amyloid in the hippocampus. We found that, in addition to activation of ERK MAPK and its downstream target ribosomal S6 kinase in hippocampal slice cultures following acute exposure to oligomeric beta-amyloid(1-42), ERK activation also requires phosphoinositide-3 kinase activity. These effects were contingent on the alpha7 subtype of nicotinic acetylcholine receptor. Hippocampal slice cultures treated acutely with oligomeric beta-amyloid(1-42) did not exhibit JNK MAPK activation; however, chronic exposure to oligomers or high molecular weight aggregates of beta-amyloid(1-42) led to JNK MAPK activation coincident with ERK MAPK down-regulation. In contrast to the effects of acute application of oligomeric beta-amyloid(1-42), nicotine activated ERK MAPK via alpha7 nicotinic acetylcholine receptors utilizing protein kinase A as an intermediate. In conclusion, we found that both the physical state and duration of exposure to beta-amyloid are determinants of MAPK recruitment in hippocampus. We also found that nicotine and beta-amyloid activate ERK MAPK via alpha7 nicotinic acetylcholine receptors but use distinct intermediate kinases. These data indicate the existence of differential coupling of alpha7 to downstream targets depending on the type of ligand that leads to receptor activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447668     DOI: 10.1111/j.1471-4159.2004.02722.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

Review 2.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

Review 3.  Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.

Authors:  Jianping Guo; Ji Cheng; Brian J North; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-07-08       Impact factor: 10.680

4.  Regulation of presynaptic Ca2+, synaptic plasticity and contextual fear conditioning by a N-terminal β-amyloid fragment.

Authors:  James L M Lawrence; Mei Tong; Naghum Alfulaij; Tessi Sherrin; Mark Contarino; Michael M White; Frederick P Bellinger; Cedomir Todorovic; Robert A Nichols
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

5.  Role of key aromatic residues in the ligand-binding domain of alpha7 nicotinic receptors in the agonist action of beta-amyloid.

Authors:  Mei Tong; Komal Arora; Michael M White; Robert A Nichols
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

6.  Nicotinic Acetylcholine Receptors Sensitize a MAPK-linked Toxicity Pathway on Prolonged Exposure to β-Amyloid.

Authors:  Komal Arora; Justin Cheng; Robert A Nichols
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

7.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

8.  Defining pre-synaptic nicotinic receptors regulated by beta amyloid in mouse cortex and hippocampus with receptor null mutants.

Authors:  Tejal K Mehta; John J Dougherty; Jianlin Wu; Catherine H Choi; Ghous M Khan; Robert A Nichols
Journal:  J Neurochem       Date:  2009-03-28       Impact factor: 5.372

9.  Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression.

Authors:  Jessica L Banko; Lingfei Hou; Francis Poulin; Nahum Sonenberg; Eric Klann
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

10.  NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures.

Authors:  Faridis Serrano; Angela Chang; Caterina Hernandez; Robia G Pautler; J David Sweatt; Eric Klann
Journal:  Mol Brain       Date:  2009-10-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.